These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels. Zeyer KA, Reinhardt DP. Mutat Res Rev Mutat Res; 2015; 765():7-18. PubMed ID: 26281765 [Abstract] [Full Text] [Related]
12. [Molecular biological aspects of Marfan syndromes]. Belsing TZ, Lund AM, Abildstrøm SZ, Søndergaard L, Friis-Hansen L. Ugeskr Laeger; 2011 Jan 31; 173(5):333-7. PubMed ID: 21276395 [Abstract] [Full Text] [Related]
13. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. Ramirez F, Dietz HC. J Cell Physiol; 2007 Nov 31; 213(2):326-30. PubMed ID: 17708531 [Abstract] [Full Text] [Related]
14. Recent progress towards a molecular understanding of Marfan syndrome. Dietz HC, Loeys B, Carta L, Ramirez F. Am J Med Genet C Semin Med Genet; 2005 Nov 15; 139C(1):4-9. PubMed ID: 16273535 [Abstract] [Full Text] [Related]
19. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells. Quarto N, Li S, Renda A, Longaker MT. Stem Cells; 2012 Dec 15; 30(12):2709-19. PubMed ID: 23037987 [Abstract] [Full Text] [Related]